Nurokind-Next Capsule

Overview Nurokind-Next Capsule

Nurokind-Next capsules combine benfotiamine, mecobalamin, alpha-lipoic acid, pyridoxine, folic acid, biotin, and chromium. Benfotiamine, a key component, boosts transketolase activity, mitigating the accumulation of harmful glucose byproducts (advanced glycation end products or AGEs) linked to diabetic complications, including retinopathy. It, along with alpha-lipoic acid, is a leading therapeutic option for diabetic neuropathy. Biotin optimizes glucose processing and improves insulin responsiveness in muscles, while chromium helps regulate blood glucose and HbA1c in type 2 diabetes. Nurokind-Next capsules are indicated for diabetic neuropathy, nephropathy, retinopathy, cardiovascular disease, and alcoholic neuropathy; use should be under professional medical guidance.